Fig. 3.

a Figure showing individual treatment regimen of patients (y-axis) during the first 12 weeks after disease onset (x-axis). Acute treatment is shown by different symbols (IVIG intravenous immunoglobulins, PEX plasma exchange, IVMPS intravenous methylprednisolone). Induction of long-term treatment is shown by lines, administrations are marked with an x. Patient seven did not receive long-term treatment during the first 12 weeks of disease. b Figure showing length and treatment regimen of long-term treatment. Administrations of rituximab/cyclophosphamide are marked with an x. Relapses are marked with an arrow